Activity vs Effectiveness: What FDA Really Wants to See
The GMP Insider · Tushar Arora
Audio is streamed directly from the publisher (podserve.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In Quality Assurance, activity is often mistaken for effectiveness. CAPAs are closed, training is completed, and SOPs are revised — but the underlying system may still remain weak.
In this episode of The GMP Insider, we explore why FDA inspections focus not only on whether actions were taken, but on whether those actions actually improved control and reduced risk.
Discussion topics include:
• The difference between completing actions and achieving effectiveness
• Why CAPA closure does not always mean recurrence was prevented
• The limitations of common quality metrics
• How FDA evaluates risk reduction and process improvement
• Why stronger systems require more than box-checking
Quality is not measured by how much activity happened. It is measured by whether the risk went down.